Key Highlights
- Dr. Tatiana Novobrantseva joins NextPoint Therapeutics as Chief Scientific Officer, bringing her significant experience in immunology, cancer, and drug development.
- Her expertise includes immuno-oncology, autoimmunity, and fibrosis, with a strong background in developing novel immunotherapies and leading discovery projects.
- Previous roles include co-founding Verseau Therapeutics and leadership positions at Moderna and Jounce Therapeutics, showcasing her strategic leadership and entrepreneurial spirit.
- Dr. Novobrantseva’s appointment is deemed pivotal for NextPoint’s growth as the company advances its precision immuno-oncology programs.
- She is also recognized for her contributions to the scientific community, serving on various advisory boards and mentorship organizations.
Source: Business Wire
Notable Quotes
- “Tatiana is a star in the immuno-oncology world, and we are thrilled to welcome her to the NextPoint team,” – Detlev Biniszkiewicz, PhD, Chief Executive Officer at NextPoint Therapeutics
- “NextPoint takes a highly innovative approach to harnessing the immune system to fight cancer, which has been a personal mission of mine for more than a decade,” – Dr. Tatiana Novobrantseva, Chief Scientific Officer at NextPoint Therapeutics
SoH's Take
The appointment of Dr. Tatiana Novobrantseva as Chief Scientific Officer at NextPoint Therapeutics marks a significant milestone in the company’s journey towards pioneering new frontiers in immuno-oncology. With her impressive track record in the field, including her leadership roles and successful tenure at Verseau Therapeutics and Moderna, Dr. Novobrantseva is uniquely positioned to lead NextPoint’s ambitious programs. Her expertise will be instrumental in advancing NextPoint’s cutting-edge research on the HHLA2 pathway, potentially offering new hope for patients with intractable cancers. This move not only strengthens NextPoint’s leadership team but also signals a clear commitment to innovation and excellence in cancer research, an area of high interest and necessity in the medical community.
